Fig. 3
From: Hsa-miR-21 promoted the progression of lung adenocarcinoma by regulating LRIG1 expression
Hsa-miR-21 could effectively predict the prognosis of LUAD patients through modulating LRIG1 expression. (A) The survival rate of patients with hsa-mir-21 high and low expression groups in TCGA-LUAD cohort. (B) The area under curves (AUCs) of 1-, 3-, and 5-year overall survival in TCGA-LUAD cohort. (C) The survival rate of patients in the different groups in TCGA-LUAD cohort. (D-E) The tumor somatic mutation (TMB) in hsa-mir-21 high and low expression groups